EUVIMEDEUVIMED entdecken
Crossref

Accurate verification of nicotine and tobacco product use or abstinence using a multi-biomarker approach

Amin Sajid, Nikola Pluym, Therese Burkhardt, Jonathan Belsey, Isaac John, Riccardo Polosa, Max Scherer

Journal of Environmental Exposure Assessment · 12.02.2026 · 5 (1)

DOI: 10.20517/jeea.2025.69 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Environmental Exposure Assessment, online erschienen am 12.02.2026. Verfasst von Amin Sajid und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cigarette smokers are exposed to over 7,000 chemicals, including many toxic and carcinogenic agents. Alternative non-combustible nicotine products considerably reduce exposure to harmful constituents. Extensive research on biomarkers of potential harm is crucial for assessing the early health impacts of smoking and the reduction of harm after quitting or switching to alternative products. However, such clinical trials are constrained by poor verification of self-reported product use, as common procedures using exhaled carbon monoxide (eCO) and cotinine strip tests are limited by short detection periods and non-specificity, respectively. Therefore, product-use-specific biomarkers of exposure (BoEs) are needed for accurate biochemical verification in studies evaluating the health impact of new products, such as electronic cigarettes. We conducted a cross-sectional study in 180 participants, including current, former, and never-smokers, and applied several BoEs to verify their use behavior. Our multi-biomarker approach monitored exposure to nicotine, tobacco-specific nitrosamines, acrylonitrile and propylene glycol (PG), which were significantly elevated in the current smoker group except PG, identifying six non-compliant subjects (4 current, 1 former and 1 never-smoker). The proposed biomarker panel outperformed eCO and was able to distinguish distinct use patterns, such as vaping vs. smoking, thereby enhancing data accuracy. Moreover, biochemically determined exposure variables such as carboxyhemoglobin and cotinine showed stronger correlations with BoEs than self-reported cigarette consumption. Therefore, the suggested panel is particularly valuable for non-controlled studies, where reliance on self-report can bias outcomes. Implementing the proposed verification strategy can improve study validity and strengthen evidence on the health impacts of switching to alternative products.

Zitieren

APA

Sajid, A., Pluym, N., Burkhardt, T., Belsey, J., John, I., Polosa, R., & Scherer, M. (2026). Accurate verification of nicotine and tobacco product use or abstinence using a multi-biomarker approach. Journal of Environmental Exposure Assessment, 5(1). https://doi.org/10.20517/jeea.2025.69

Vancouver

Sajid A, Pluym N, Burkhardt T, Belsey J, John I, Polosa R, et al. Accurate verification of nicotine and tobacco product use or abstinence using a multi-biomarker approach. Journal of Environmental Exposure Assessment. 2026;5(1). doi:10.20517/jeea.2025.69

BibTeX
@article{Sajid2026,
  author = {Sajid, Amin and Pluym, Nikola and Burkhardt, Therese and Belsey, Jonathan and John, Isaac and Polosa, Riccardo and Scherer, Max},
  title = {Accurate verification of nicotine and tobacco product use or abstinence using a multi-biomarker approach},
  journal = {Journal of Environmental Exposure Assessment},
  year = {2026},
  volume = {5},
  number = {1},
  doi = {10.20517/jeea.2025.69}
}
Kostenlos starten →